FDA approves Combivir ANDAs from Lupin and Aurobindo; GSK’s main Orange Book patent on Combivir expired two days ago.
Several other applicants previously received tentative approvals, which can now be converted into full approvals. However, none of these companies will make any meaningful money from selling their generics insofar as Combivir has been superseded by Truvada and is an obsolete product.
Market Data 
Markets 
AI
